Plant Health Care plc (LON:PHC), a leading provider of novel patent-protected biological products to global agriculture markets, today announced a new distribution agreement with Wilbur-Ellis Company LLC, a leading U.S.
Plant Health Care (LON: PHC), a leading provider of novel patent-protected biological products to the global agriculture markets, announced today its preliminary results for the full year ended 31 December 2018.
Path Investments plc (LON: PATH) today provided an update regarding the Heads of Agreement with ARC Marlborough Pty Limited (“ARC”) in relation to the proposed acquisition of ARC by the
Chris Richards, Plant Healthcare Executive Chairman & Interim CEO, said: “We are excited about the potential for the product pipeline now coming out of our PREtec technology. These products are
Chris Richards, Plant Health Care Interim CEO, commented: “Plant Health Care continued to make exciting progress in 2018, in spite of recently announced set-backs. The launch of our new corn
Chris Richards, Plant Health Care Executive Chairman & Interim CEO, said “As we continue to generate positive results from our PREtec platform of peptides, we are delighted to expand our
Chris Richards, Executive Chairman and Interim CEO of Plant Health Care noted: “This award is recognition that Plant Health Care, as a science-based company, can bring new benefits to growers
Plant Health Care (LON: PHC), a leading provider of novel patent-protected biological products to global agriculture markets, today announced that the Company will be presenting at the Mello London investor
Chris Richards, Executive Chairman and Interim CEO of Plant Health Care, noted: “Grower reaction to demonstration trials of H2Copla has been very positive. Growers have already treated some 20,000 Ha
Plant Health Care’s Dr Chris Richards discusses the progress of corn in the US, Harpin ?β in Brazil, getting to a cash flow positive, their new Plant Response Elicitor technology and plans for the future. in this exclusive interview with DirectorsTalk
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
